EZH2 and neoplasm: OC studied more comprehensively for oncological suppressive effects, exhibiting broad anticancer activity by targeting oncogenic mediators including c-MET, SMYD2, and EZH2, thereby suppressing tumor proliferation, invasion, progression, and recurrence in multiple cancer types, including breast, colorectal, and metastatic CRPC models [23,24,25].